Delivery Order SPE2DB25D3404-SPE2DB25FUPAC
Award Date 6/26/25
Potential Completion Date 6/27/25
Potential Value $3.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,292.74 contract is for the delivery of VYVANSE 30 MG CAPSULE 100S, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a firm-fixed price pricing type and an ultimate completion date of December 12, 2023. This delivery order is part of a...
- This is a $3,148.00 delivery order contract awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of VYVANSE 40 MG CAPSULE 100S, a medication used for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD). The contract has an ultimate completion date of February 4, 2025 and is a firm fixed-price contract. The contract is not designated as...
- This is a $10,510.50 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of VYVANSE capsules, a medication used to treat ADHD. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, which provides a broad range of pharmaceutical products and medical...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,948.02, is for the delivery of VYVANSE 10 MG CAPSULE 100S, a prescription medication used for the treatment of attention deficit hyperactivity disorder (ADHD). The contract has an ultimate completion date of October 17, 2024. This award is part of a larger Indefinite...
- This is a $4,915.14 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4567615693 VYVANSE 30 MG CAPSULE 100S, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of March 19, 2025 and was awarded on March 18, 2025. The contract is not designated as a...
- This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,989.95 firm fixed-price delivery order is for the supply of VYVANSE 10 MG CAPSULE 100S, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of March 14, 2025 and was awarded on March 13, 2025. It is not designated as a set-aside...
- This is a $16,283.90 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of VYVANSE CAPS 70MG, a medication used to treat ADHD. It is not a set-aside contract, indicating open competition. The contract has an ultimate completion date of June 12, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,979.81 firm fixed-price delivery order is for the supply of VYVANSE 10 MG CAPSULE 100S, a medication used for the treatment of attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of April 2, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract...
- This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of VYVANSE 10 MG CAPSULE 100S, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a ceiling value of $5,704.50 and is a firm fixed-price delivery order, with an ultimate completion date of July 9, 2025. The contract is not set aside...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,973.32, is for the supply of VYVANSE 70 MG CAPSULE 100S, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of June 20, 2024 and is a firm-fixed-price delivery order. The contract is not designated as a set-aside....